Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide (Wegovy) can affect blood pressure in ways that matter to people already managing hypertension or cardiovascular risk. Clinical trial data show blood pressure changes are possible during treatment, both as a direct effect and as a consequence of weight loss itself. These are prescription-only medicines, and a prescriber assesses your blood pressure history before any treatment begins. This page sets out what the evidence shows, what to watch for, and when to act.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear most weeks, usually from people who already take medication for high blood pressure and want to know whether semaglutide will push things in the wrong direction. The short answer is: for most people, it doesn't. In the STEP 1 clinical trial, published in the New England Journal of Medicine, participants on semaglutide 2.4mg showed modest reductions in systolic blood pressure alongside significant weight loss over 68 weeks.
Weight itself is one of the strongest drivers of elevated blood pressure, so as body weight falls, blood pressure often follows. That said, semaglutide also has direct cardiovascular effects that are still being characterised. For people whose blood pressure is already well-controlled on medication, the combination can occasionally tip systolic readings lower than expected. That's not always a problem, but it's worth knowing.
What you shouldn't expect is a dramatic or sudden spike in blood pressure caused by Wegovy itself. The NHS medicines page for semaglutide does not list hypertensive crisis among its known side effects. The picture is more nuanced than that, and nuance matters when you're making a decision about treatment.
A modest, gradual reduction in blood pressure is usually welcome news. The situations that need closer attention are at the edges: readings that drop low enough to cause dizziness or fainting, particularly on standing, and any sharp or unexpected rise that sits outside your usual range.
Dizziness and light-headedness are listed side effects of Wegovy, and they can sometimes reflect a blood-pressure drop rather than anything to do with nausea or dehydration. If you notice this reliably when standing up, mention it to your prescriber. It may simply mean your antihypertensive dose needs reviewing as you lose weight — a normal and manageable adjustment, not a crisis.
The more urgent signals are different in character: a sudden, severe headache unlike any you've had before, chest pain or tightness, blurred vision, or difficulty speaking. These symptoms are not typical Wegovy side effects. They need emergency medical attention. Call 999 or go to A&E. Do not wait for a callback from any online pharmacy, including us.
For further context on how semaglutide specifically relates to blood pressure management, the question of Wegovy's safety in people with high blood pressure is covered in more depth on a dedicated page.
This is a connection that's easy to miss. Nausea, vomiting, and diarrhoea are the most commonly reported side effects in the early weeks of treatment, and severe or prolonged episodes can lead to dehydration. Dehydration reduces circulating blood volume, and that can lower blood pressure more sharply than weight loss alone would.
If you're vomiting repeatedly and can't keep fluids down, your blood pressure may fall enough to cause significant light-headedness or weakness. At that point, the concern isn't just discomfort, it's a physiological chain reaction that can put strain on the kidneys and cardiovascular system. The NHS advises seeking medical help if you cannot keep any fluid down for more than 24 hours, and that guidance applies here. Any situation involving blood appearing in vomit is a medical emergency without exception.
Most GI side effects settle as your body adjusts to each dose level, typically within the first one to two weeks after a change. Staying well-hydrated, eating smaller portions, and avoiding very fatty meals in early treatment all reduce the severity. Your prescriber or the aftercare team can give specific advice through the process.
Choosing to start Wegovy when you have a blood pressure history isn't a simple yes-or-no. Your prescriber looks at the full picture: your current readings, what medications you're on, your wider cardiovascular risk, and what you stand to gain from meaningful weight loss. For many people, those gains are substantial, sustained weight reduction of around 15% has meaningful knock-on benefits for blood pressure, left ventricular load, and overall cardiovascular risk.
At the same time, if your blood pressure is poorly controlled or fluctuating, that's a conversation to have before starting, not after. It's also worth knowing that some people notice no side effects on Wegovy at all, while others find that mood changes are part of their experience, which is why the relationship between semaglutide and depression is something prescribers take seriously during review. The consultation at nume is reviewed personally by a GPhC-registered prescriber, not processed by software, and blood pressure and cardiovascular history are part of every clinical review. If something isn't quite right for treatment to begin, you'll be told plainly, with reasons.
If you're comparing how semaglutide's cardiovascular side-effect profile sits relative to tirzepatide's, the Mounjaro versus Wegovy side effects comparison covers that ground with a balanced summary. And the broader Wegovy side effects overview gives context for all commonly reported effects, not just those linked to blood pressure.
If you have questions or concerns about your specific situation before you're ready to consult, you can reach us through the contact page. When you're ready to talk it through with a prescriber, starting a free consultation is the next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.